RAB5A, Member RAS Oncogene Family (RAB5A) (Middle Region) Peptide
RAB5A
Reactivité: Humain
Hôte: Synthetic
BP, WB, IHC
N° du produit ABIN982573
Aperçu rapide pour RAB5A, Member RAS Oncogene Family (RAB5A) (Middle Region) Peptide (ABIN982573)
Antigène
RAB5 (RAB5A)
(RAB5A, Member RAS Oncogene Family (RAB5A))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Protein Region
- Middle Region
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-RAB5A antibody (Catalog #: ARP56563_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- RAB5 (RAB5A) (RAB5A, Member RAS Oncogene Family (RAB5A))
-
Sujet
-
RAB5A is required for the fusion of plasma membranes and early endosomes.
Alias Symbols: RAB5
Protein Interaction Partner: EEA1,RAB5A,AGTR1,ALS2CL,APPL1,APPL2,CHML,EEA1,GDI2,OCRL,RAB37,RAB5A,RABAC1,RABEP1,RABGGTB,RASA1,RIN1,RIN2,SDCBP,STX4,TBC1D3C,TBC1D3F,TSC2,USP6NL,ZFYVE20,AGTR1,ALS2CL,AP1G1,AP1G2,CHM,CHML,EEA1,GDI2,GGA1,GGA2,GGA3,KIF3B,RAB37,RAB4A,RAB4A,RAB7A,RABEP1,RABEP2,RIN1,RIN2,RIN3,RIT2,SDCBP,STX4,TSC2,VPS45,ZFYVE20
Protein Size: 215 -
Poids moléculaire
- 24 kDa
-
ID gène
- 5868
-
NCBI Accession
- NM_004162, NP_004153
-
UniProt
- P20339
Antigène
-
Vous êtes ici:
